Talis Biomedical Corp (TLIS)
NGM · Common · CUSIP 87424L108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TLIS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
87424L108
Market Cap
Micro Cap · $52 Million
IPO
2/12/2021 · $16.00/share
Business: Talis Biomedical Corp is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care. The company is developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform.

Company Contact

CEO
Rob Kelley
CFO
J. Roger Moody, Jr.
Headquarters
230 Constitution Drive, Menlo Park, CA 94025
Phone
650-433-3000
Investor Relations
Emily Faucette · 415-595-9407 · efaucette@talisbio.com
SEC EDGAR Filings
View filings »